Filing Details
- Accession Number:
- 0001140361-15-009491
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-27 19:21:50
- Reporting Period:
- 2015-02-25
- Filing Date:
- 2015-02-27
- Accepted Time:
- 2015-02-27 19:21:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1213037 | Trovagene Inc. | TROV | Biological Products, (No Disgnostic Substances) (2836) | 043721895 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1166309 | Bridger Management, Llc | 90 Park Avenue 40Th Floor New York NY 10016 | No | No | Yes | No | |
1258394 | Roberto Mignone | 90 Park Avenue 40Th Floor New York NY 10016 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.0001 Par Value Per Share | Acquisiton | 2015-02-25 | 105,142 | $5.12 | 2,692,443 | No | 4 | P | Indirect | See footnotes |
Common Stock, $.0001 Par Value Per Share | Acquisiton | 2015-02-26 | 78,801 | $5.42 | 2,771,244 | No | 4 | P | Indirect | See footnotes |
Common Stock, $.0001 Par Value Per Share | Acquisiton | 2015-02-27 | 79,343 | $5.62 | 2,850,587 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Footnotes
- The price reported in Column 4 is a weighted average price, rounded to the nearest whole cent. These Shares (as defined below) were purchased in multiple transactions at prices ranging from $4.84 to $5.20, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The shares of Common Stock, $.0001 par value per share (the "Shares") reported herein as indirectly beneficially owned by the Reporting Persons are held of record by Swiftcurrent Partners, L.P., Swiftcurrent Offshore Master Ltd. and Bridger Healthcare Ltd. Bridger Management, LLC is the investment adviser to Swiftcurrent Partners L.P., Swiftcurrent Offshore Master Ltd., and Bridger Healthcare Ltd., and as such, may be deemed to share beneficial ownership of the Shares. Roberto Mignone is the managing member of Bridger Management, LLC.
- Each reporting person and entity named herein disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein and this report shall not be deemed an admission that the reporting person or any entity named herein is the beneficial owner of the securities for purposes of Section 16, or for any other purpose.
- The price reported in Column 4 is a weighted average price, rounded to the nearest whole cent. These Shares were purchased in multiple transactions at prices ranging from $5.25 to $5.50, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnote (4) to this Form 4.
- The price reported in Column 4 is a weighted average price, rounded to the nearest whole cent. These Shares were purchased in multiple transactions at prices ranging from $5.50 to $5.65, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnote (5) to this Form 4.